Save time and jump to the most important pieces.
Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
11/21/2024 | $91.00 | Buy → Hold | DZ Bank | |
11/20/2024 | $92.00 → $100.00 | Outperform | Telsey Advisory Group | |
11/20/2024 | $925.00 → $1100.00 | Buy | Pivotal Research Group | |
11/18/2024 | $60.00 → $66.00 | Equal Weight → Overweight | Wells Fargo | |
10/22/2024 | $95.00 | Outperform | Bernstein | |
10/18/2024 | $775.00 → $825.00 | Outperform | Oppenheimer | |
10/18/2024 | $900.00 → $925.00 | Buy | Pivotal Research Group | |
10/18/2024 | $700.00 → $800.00 | Buy | Needham |
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
4 - CVS HEALTH Corp (0000064803) (Issuer)
BENTONVILLE, Ark., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Walmart and the National Fish and Wildlife Foundation (NFWF) today announced a 10-year, $34.5 million renewal of the historic Acres for America conservation program. This new commitment from Walmart, combined with previous contributions, represents the largest corporate donation to NFWF since the Foundation's creation by Congress in 1984, for a total of more than $100 million since the program began. Acres for America began in 2005, when Walmart U.S. made its first commitment of $34.5 million to NFWF to fund the conservation of one acre of wildlife habitat for every acre of land developed in the United States — estimated to be approxim
WOONSOCKET, R.I., Nov. 19, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Dr. Sreekanth Chaguturu will be President, Health Care Delivery, in addition to his current role as Executive Vice President and Chief Medical Officer of CVS Health. Dr. Chaguturu replaces Mike Pykosz, who has decided to leave the company. "Sree and I worked closely together when he started at CVS Health, serving as chief medical officer of CVS Caremark. In that role, and as the leader of Medical Affairs at our company, Sree has served as a trusted advisor to our clients, their members
eCommerce up 27% globally GAAP EPS of $0.57; Adjusted EPS of $0.58 Company raises guidance for FY25 Walmart Inc. (NYSE:WMT): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241118919925/en/ Third Quarter Highlights: Consolidated revenue of $169.6 billion, up 5.5%, or 6.2% (cc) Consolidated gross margin rate up 21 bps, led by Walmart U.S. Consolidated operating income up $0.5 billion, or 8.2%; up 9.8% (cc) due to higher gross margins and growth in membership income; also benefited from reduced losses in eCommerce ROA at 7.8%, ROI at 15.1%, up 100 bps Global eCommerce sales grew 27%, led by store fulfilled pick
CVS Health Board of Directors appoints four new members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman Appointments follow productive engagement with Glenview Capital Management WOONSOCKET, R.I., Nov. 18, 2024 /PRNewswire/ -- The Board of Directors of CVS Health (NYSE:CVS) today announced the appointment of four new board members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman, following productive discussions with Glenview Capital Management. "In our discussions with the leadership at Glenview, we agreed that we can deliver greater value from our
Prem Shah named Group President, CVS Health; Steve Nelson named President, Aetna WOONSOCKET, R.I., Nov. 6, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced Prem Shah will be Group President, and will continue to report to David Joyner, President and Chief Executive Officer. In addition, the company announced the appointment of Steve Nelson as President, Aetna, and he will also report to Joyner. Both appointments are effective today. As Group President, Shah will be responsible for the operational performance and integrated value creation across CVS Caremark, CVS Pha
Roger Farah Named Executive Chairman of the Board Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10 WOONSOCKET, R.I., Oct. 18, 2024 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced that David Joyner was appointed President and Chief Executive Officer, effective October 17, replacing Karen Lynch, who stepped down from her position in agreement with the company's Board of Directors. Joyner also joined the Board of Directors. In addition, current Chairman of the Board, Roger Farah, will now be Executive Chairman.
DZ Bank downgraded Walmart from Buy to Hold and set a new price target of $91.00
Telsey Advisory Group reiterated coverage of Walmart with a rating of Outperform and set a new price target of $100.00 from $92.00 previously
Pivotal Research Group reiterated coverage of Netflix with a rating of Buy and set a new price target of $1,100.00 from $925.00 previously
8-K - Walmart Inc. (0000104169) (Filer)
8-K - CVS HEALTH Corp (0000064803) (Filer)
6-K - Beamr Imaging Ltd. (0001899005) (Filer)
eCommerce up 27% globally GAAP EPS of $0.57; Adjusted EPS of $0.58 Company raises guidance for FY25 Walmart Inc. (NYSE:WMT): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241118919925/en/ Third Quarter Highlights: Consolidated revenue of $169.6 billion, up 5.5%, or 6.2% (cc) Consolidated gross margin rate up 21 bps, led by Walmart U.S. Consolidated operating income up $0.5 billion, or 8.2%; up 9.8% (cc) due to higher gross margins and growth in membership income; also benefited from reduced losses in eCommerce ROA at 7.8%, ROI at 15.1%, up 100 bps Global eCommerce sales grew 27%, led by store fulfilled pick
Walmart Inc. (NYSE:WMT) announced it will hold a live conference call with the Investment Community at 7 a.m. CST on Tuesday, November 19th, 2024, to discuss the company's third quarter earnings results for fiscal year 2025. Doug McMillon, president and chief executive officer, and John David Rainey, executive vice president and chief financial officer, will host the call to discuss the results and answer questions. The event will be webcast live and is accessible by visiting corporate.walmart.com/news/events and selecting the Third Quarter Earnings Release event. The webcast will be archived and available on the company website. The company will release its third quarter earnings resul
Financial Highlights Third quarter total revenues increased to $95.4 billion, up 6.3% compared to the prior yearThird quarter GAAP diluted EPS of $0.07 and Adjusted EPS of $1.09Third quarter GAAP diluted EPS and Adjusted EPS include charges to record premium deficiency reserves of approximately $1.1 billion ($0.63 per share) in the Health Care Benefits segmentGenerated year-to-date cash flow from operations of $7.2 billionCEO Commentary "Our integrated model accelerates our ability to uniquely do what is most important to today's health care consumers: deliver lower cost of care, a simpler experience and better outcomes. Our third quarter results reflect strong performance in the Health Serv
Financial giants have made a conspicuous bullish move on CVS Health. Our analysis of options history for CVS Health (NYSE:CVS) revealed 10 unusual trades. Delving into the details, we found 50% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $374,736, and 7 were calls, valued at $388,184. Expected Price Movements Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $53.0 to $77.5 for CVS Health over the last 3 months. Analyzing Volume & Open Interest Assessing the volume and open interest is a strategic step in options trading. These metr
Costco Wholesale Corp (NASDAQ:COST) share price has been on a remarkable ascent, trading above $800. This puts the retail giant in prime stock-split territory. Historically, stock splits occur after substantial price increases, and Costco’s impressive growth makes it a noteworthy candidate for such a move. Will Costco Follow Rival Walmart’s Footsteps? Walmart Inc‘s (NYSE:WMT) 3-for-1 stock split, initiated when its shares were trading below $200, sets a precedent. Costco’s stock price has far surpassed this level, climbing nearly 30% year-to-date and almost tripling over the past five years. The company's consistent performance and its share price near record highs suggest it could
This was a fascinating week featuring political shifts, increased market volatility, and a week-long drop in the stock prices of the mega-cap tech leaders that have been supporting the equity market indexes the past couple of years. This week, we’re focused on higher retail sales and wondering if anything will slow the consumer. Higher jobless claims make people think the Fed is almost 100% certain to cut rates by September. China is trying to keep its banks from imploding. Treasury Secretary, Yellen, is shortening the duration of the government bond market leading to larger auctions with less comparative demand. (Don’t worry – we’ll explain.) Finally, I address some critics who insist that
SC 13G/A - Beamr Imaging Ltd. (0001899005) (Subject)
SC 13G - CVS HEALTH Corp (0000064803) (Subject)
SC 13G - Beamr Imaging Ltd. (0001899005) (Subject)
4 - Walmart Inc. (0000104169) (Issuer)
4 - Walmart Inc. (0000104169) (Issuer)
4 - NETFLIX INC (0001065280) (Issuer)